谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

LBA10 Primary Endpoint Results of the Neo-CheckRay Phase II Trial Evaluating Stereotactic Body Radiation Therapy (SBRT) +/- Durvalumab (durva) +/- Oleclumab (ole) Combined with Neo-Adjuvant Chemotherapy (NACT) for Early-Stage, High Risk ER+/HER2- Breast Cancer (BC)

A. De Caluwe,I. Desmoulins, K. Cao,V. Remouchamps, A. Baten,E. Longton,K. Peignaux-Casasnovas,G. Nader-Marta,L. Arecco,E. Agostinetto, P. Kristanto, X. Catteau,D. Larsimont,R.F. Salgado,C. Sotiriou,P. Poortmans,M. Piccart,M. Ignatiadis,E. Romano,L. Buisseret

Annals of Oncology（2024）

引用 0|浏览3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要